新生儿重症监护室的高卡血症:实际的还是伪高卡血症?
1Department of Pediatrics, Faculty of Medicine, Kocaeli University, Kocaeli, Türkiye.
Postgraduate medicine
|December 10, 2025
概括
超血是新生儿重症监护室 (NICU) 中的一个危急病症. 从伪高血症区分真正的高血症至关重要,因为实际的高血症显著增加新生儿的死亡风险.
科学领域:
- 新生儿科学 新生儿科学
- 儿科脏病学 儿科脏病学
- 临床化学 临床化学
背景情况:
- 高血是新生儿重症监护室 (NICU) 中严重的电解质失衡,与死亡率增加有关.
- 准确区分真实和伪高血症对于新生儿的适当管理至关重要.
研究的目的:
- 为了确定10年内新生儿重症监护室住院患者中高血的患病率,病因因素和临床结果.
- 使用基于妊娠年龄的门来区分真实高卡利米亚和伪高卡利米亚.
主要方法:
- 对10年NICU入院数据的分析.
- 根据妊娠年龄 (≥6 mmol/L为期,>6.5 mmol/L为早产) 定义的高卡莱米亚值.
- 评估了伪高血症,主要病因和死亡率.
主要成果:
- 在4.9%的入院病例中观察到高血症;真正的高血症在1.6%中.
- 伪高血症更为常见;实际的高血症在新生儿中更为频繁.
- 急性损伤 (AKI) 影响率为43.6%;死亡率为37.2%的实际高血症与7.2%没有.
结论:
- 超血是NICU的一个重大问题,需要立即将伪超血与真正的超血区分开来.
- 实际的高血症具有很高的死亡风险,这强调了需要快速,病因特异性的治疗和降疗法.
相关概念视频
Acute Kidney Injury V: Interprofessional Care
277
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
277
Acute Kidney Injury VI: Nursing Management
362
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
362
Antihypertensive Drugs: Potassium-Sparing Diuretics
2.2K
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
2.2K
Pharmacokinetics in Pediatric Patients: Drug Distribution
240
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
240
Pharmacokinetics in Pediatric Patients: Drug Excretion
194
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
194
Pharmacokinetics in Pediatric Patients: Drug Metabolism
174
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
174


